Related references
Note: Only part of the references are listed.Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations
X. Moisset et al.
REVUE NEUROLOGIQUE (2020)
The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises
Srinivasa N. Raja et al.
PAIN (2020)
QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France
Michel Lanteri-Minet et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Neuropathic pain: Definition, assessment and epidemiology
D. Bouhassira
REVUE NEUROLOGIQUE (2019)
Pharmacological treatments of neuropathic pain: The latest recommendations
N. Attal
REVUE NEUROLOGIQUE (2019)
Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain A 52-Week, Open-Label, Single-Arm, Safety Study
Rafael Galvez et al.
CLINICAL JOURNAL OF PAIN (2017)
Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
M. Haanpaa et al.
EUROPEAN JOURNAL OF PAIN (2016)
Capsaicin Cutaneous Patch: a Cost-consequences Study in a French University Hospital
Maud Schweitzer et al.
THERAPIE (2015)
Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
Kai-Uwe Kern et al.
PAIN PRACTICE (2014)
Transient Receptor Potential Channels in Pain and Inflammation: Therapeutic Opportunities
Mark A. Schumacher
PAIN PRACTICE (2010)
Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain
Sunita Babbar et al.
THERAPEUTIC DRUG MONITORING (2009)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
Share Paper
